Antioxidant status in patients with hyperplasia and prostate cancer
Journal of Biomedical and Clinical Research · 2024
DOI: 10.3897/jbcr.e125424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical and Clinical Research, 2024. Verfasst von Teodora M. Velkovska und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This review aims to briefly describe and summarize data from various studies on the role and the link between serum Total Antioxidant Status (TAS) levels in patients with BPH and PC, as well as other more widely available endogenous antioxidants, the levels of markers of inflammation (CRP, Leuc.), as well as the link between the values of endogenous antioxidants and various harmful factors. Their levels and adequate assessment could help in the proper management of patients with BPH and PC, as well as in reducing morbidity.
Zitieren
APA
Velkovska, T. M., & Ruseva, A. L. (2024). Antioxidant status in patients with hyperplasia and prostate cancer. Journal of Biomedical and Clinical Research. https://doi.org/10.3897/jbcr.e125424
Vancouver
Velkovska TM, Ruseva AL. Antioxidant status in patients with hyperplasia and prostate cancer. Journal of Biomedical and Clinical Research. 2024. doi:10.3897/jbcr.e125424
BibTeX
@article{Velkovska2024,
author = {Velkovska, Teodora M. and Ruseva, Adelaida L.},
title = {Antioxidant status in patients with hyperplasia and prostate cancer},
journal = {Journal of Biomedical and Clinical Research},
year = {2024},
doi = {10.3897/jbcr.e125424}
}
EUVIMED